Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoposide/Carboplatin vs Paclitaxel/Carboplatin in Advanced LCNEC
NCT02943798Phase 2Unknown
- Sponsor
- Shanghai Chest Hospital
- Start
- Dec 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of etoposide, paclitaxel in Pulmonary Large-Cell Neuroendocrine Carcinoma (LCNEC), sponsored by Shanghai Chest Hospital. Status: unknown.
02
Drugs
etoposidepaclitaxel
03
Conditions
Pulmonary Large-Cell Neuroendocrine Carcinoma (LCNEC)
Beyond the preview
Go deeper on NCT02943798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02943798.